- Home
- BRBR vs PSNL Comparison
BRBR vs PSNL Comparison
Compare BRBR & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRBR | PSNL |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical Specialities |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BRBR | PSNL |
|---|---|---|
| Price | $9.79 | $16.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 5 |
| Target Price | ★ $36.63 | $12.20 |
| AVG Volume (30 Days) | 2.7M | ★ 3.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $2,316,600,000.00 | $69,648,000.00 |
| Revenue This Year | $6.28 | $15.34 |
| Revenue Next Year | $5.81 | $41.46 |
| P/E Ratio | $10.94 | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $7.82 | $4.96 |
| 52 Week High | $38.77 | $18.89 |
Technical Indicators
Market Signals| Indicator | BRBR | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 37.45 | 57.30 |
| Support Level | $9.22 | $7.41 |
| Resistance Level | $14.23 | $18.89 |
| Average True Range (ATR) | 0.54 | 0.88 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 9.59 | 48.43 |
Price Performance
Historical ComparisonAbout BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channel including club, food, drug and mass, eCommerce, convenience and specialty.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.